AICAR 50 mg Peptide Sciences
| Features | |
| Active substance | Peptide |
| Also known as | AICA riboside, Acadesine |
| Blood pressure | No significant effects reported |
| Chemical name | 5-Aminoimidazole-4-carboxamide ribonucleotide |
| Dosage (medical) | Not specified for human therapeutic use |
| Dosage (sports) | 50-100 mg per day |
| Effects | Increases glucose uptake in skeletal muscle tissue, endurance enhancement |
| Formula | C9H15N4O8P |
| Half-life | 2-3 hours |
| Hepatotoxicity | Low |
| Lab Test | Detection through specific blood tests |
| Main action | AMP-activated protein kinase activator |
| Side effects | Potential risk of cancer, may affect blood flow and nutrient delivery |
| Storage conditions | Store at room temperature, protect from light |
| Substance class | Nucleotide |
| Trade name | Not commercially marketed as a therapeutic drug |
| Use in sports | Banned under the World Anti-Doping Agency (WADA) for use in competitive sports |
| Water Retention | None |
| Active ingredient, mg | 50 |
| Release form | Vial |
| 1 Vial, ml | 10 |
| Vials in the package, pcs | 5 |
| Manufacturer | Peptide Sciences |
| Packing | Packing (5 bottles), Vial |